Phase II Trial of Tivozanib in Advanced Hepatocellular Cancer

NCT01807156 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

7

Enrollment

OTHER

Sponsor class

Stopped Primary endpoint not met

Conditions

Hepatocellular Cancer

Interventions

DRUG: Tivozanib

Sponsor

Emory University

Collaborators

[object Object]